Chouksey: Insurance hazard ratio modeling is 20 years outdated
Jitendra Chouksey · Ep #21 | WTF is Longevity? | Nikhil ft. Nithin Kamath, Bryan Johnson, Prashanth, Jitendra & Seema · Nikhil Kamath · Feb 2, 2025 · at 2:08:59
Fittr founder Jitendra Chouksey argues that traditional insurance underwriting models fail to capture personalized metabolic health indicators.
0:00 / 0:18exact quote · 18.4s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Today insurance companies spend a lot of people in assessing hazard ratio. Some of the things are very straightforward, but some of the, it's not a, how do you say, it's not a nuanced approach. They are still following the same approach for, you know, arriving at a hazard ratio, what they did 20 years back.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Jitendra Chouksey
Chouksey: Blue Zones Do Not Exist and Rely on Cherry-Picked Data
“Personally, I'm not very convinced on the idea of blue zones. There's a lot of data out there which suggests that blue zones are created. They don't exist. So classic case of cherry picking. And so what they have done is they have mapped certain groups of popu…”
Chouksey: Most Indian Cities Will Be Uninhabitable Within 5–10 Years
“I think next five to 10 years, most of the cities in India, well, as per WHO would be, you know, uninhabitable. When it comes to AQI and water quality”
JC: No data suggests continuous glucose monitors help non-diabetics
“CGM, again, I'm not a huge fan of CGM. It's great for diabetics, but in non-diabetics, there's no data that suggests it helps non-diabetics. I mean, apart from making people feel scared of every single food on the planet that spikes their blood glucose, and yo…”
Chouksey: Andrew Huberman has a conflict of interest through an AG1 investment
“So, Huberman also has a conflict of interest, because AGI promises they have all of these things, and Huberman has an investment in AGI.”
Chouksey: Fittr has no competitive moat except for its community
“Actually, at this point, to be very honest, except for the community, nothing.”
Chouksey: Bryan Johnson's experimental therapeutics are mostly unvalidated and shouldn't be preached
“What I have problem with is some of the experimental therapeutics, the hundred pills and everything. Most of these things are unvalidated. So as long as he's keeping those experiments in check and he's doing it on himself, As a science experiment? Good. I'm ju…”